Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 64 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/1/1996


1.		Phase III Randomized Double-Blind Study of SUR/HC vs Placebo/HC in Metastatic Hormone-Refractory Prostate Carcinoma with Painful Bone Metastases (Summary Last Modified 01/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				any age				Pharmaceutical / Industry				PD-1003-01 NCI-V94-0598

Last Modified: 6/1/2008 First Published: 3/1/1996


2.		Phase III Randomized Study of Low- Versus Intermediate- Versus High-Dose Suramin in Patients With Advanced Hormone-Refractory Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				CALGB-9480 E-C9480, SWOG-9452, INT-0159, NCT00002723

Last Modified: 5/10/2007 First Published: 12/1/1996


3.		Phase III Randomized Study of Orchiectomy or LHRH Analogue Plus Flutamide With or Without Suramin and Hydrocortisone in Advanced Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				E-8892 CLB-E8892, SWOG-E8892, NCT00002881, E8892

Last Modified: 4/1/2000


4.		Phase I/II Study of Sequential Suramin and Topotecan for Hormone-Refractory Prostate Cancer (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified				NCI				JHOC-9607 NCI-T95-0106H, T95-0106


5.		Phase I/II Trial of Suramin in Adult Patients with AIDS-Related Kaposi's Sarcoma or Lymphadenopathy Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				18 and over				NCI				NEDH-AIDS NCI-T85-0081D, T85-0081

Last Modified: 12/6/2007


6.		Phase I/II Study of Suramin Given by Prolonged Infusions in Patients with Hormone-Resistant Prostate Cancer and Other Advanced Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				any age				NCI				MSKCC-90126 NCI-T90-0077D, T90-0077

Last Modified: 3/17/2008 First Published: 1/26/2003


7.		Phase I/II Study of Low-Dose Suramin and Paclitaxel in Women With Stage IIIB or IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				OSU-02H0216 NCI-5851, OSU-0216, NCT00054028, 5851

Last Modified: 5/7/2008 First Published: 4/23/2004


8.		Phase I/II Study of Fluorouracil and Low-Dose Suramin as Chemosensitization in Patients With Metastatic Renal Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				CCF-6101 6036, NCI-6036, NCT00083109, CWRU-CASE-1804

Last Modified: 4/26/2007


9.		Phase II Study of Suramin for Metastatic Renal Cell Carcinoma (Summary Last Modified 07/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				IOWA-UO-9401 CCUM-9549, NCI-T94-0030D, T94-0030

Last Modified: 2/1/1997


10.		Phase II Pilot Study of Fixed-Schedule Suramin with Androgen Suppression using Orchiectomy/Flutamide or LHRH Agonist/Flutamide for Newly Diagnosed Stage D2 Prostate Cancer (Summary Last Modified 02/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				adult				NCI				SWOG-9343 SWOG-9343

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute